Please join us for a Foley web conference on Friday, March 11, where we will cover key legal issues that hospital compliance and legal teams can anticipate in preparation for the quickly approaching April 1st implementation date, including:
- CJR program overview – What you need to know
- What contracts does a CJR hospital need and what needs to be included?
- How to navigate compliance requirements and fraud and abuse considerations
- Top legal concerns in engaging providers as gainsharers
Speakers include:
Christopher Donovan, Partner, Foley & Lardner LLPAlexis Finkelberg Bortniker, Senior Counsel, Foley & Lardner LLP
Frederick Geilfuss II, Partner, Foley & Lardner LLP
This is the first in a series of web conferences on bundled payments. Future programming will cover:
- Bundled Payments and Working with Post-Acute Care Providers and
- Bundled Payments and Private Equity Opportunities
There is no cost to participate in this program but advance registration is required. To participate, please use either the Register Now button above, or simply register here.
Instructions for accessing the program will be included in the registration confirmation.
For more information, please contact Zulaikha Rahim at zrahim@foley.com.
Related Insights
June 6, 2025
Energy Current
House Bill 3809 Adds Obligations to Battery Energy Storage Lessees in Texas
On May 29, 2025, House Bill No. 3809 was signed into law by Texas Governor Greg Abbott. Born out of a crop of bills regulating renewable…
June 23, 2025
Events
Third Annual Transaction Solutions Symposium
Foley & Lardner is sponsoring the Third Annual Transaction Solutions Symposium — a premier conference focused on de-risking strategies that enhance deal execution and business outcomes. Rishi Sodhi will be speaking as part of the Tax Liability Insurance: Current Trends, Controversies and Claims panel.
June 5, 2025
Health Care Law Today
GLP-1 Compounded Medications Targeted by Connecticut Attorney General
On May 21, 2025, the Connecticut Office of the Attorney General released a statement and sent letters to Connecticut weight loss clinics, med spas, medical practices and other businesses regarding allegedly or potentially unfair and deceptive conduct relating to compounded GLP-1 medications.